COMPANY
NOVARTIS IRELAND LIMITED
NOVARTIS IRELAND LIMITED: marketing authorisation holder for Octreotide, as stated by public registers.
MARKETING AUTHORISATION HOLDER
Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).
| Octreotide | SANDOSTATIN AMPOULES 100 MCG/ML SOLUTION FOR INJECTION OR CONCENTRATE FOR SOLUTION FOR INFUSION, PL 23860/0031, Authorised Regulator MHRA |
|---|---|
| Octreotide | SANDOSTATIN AMPOULES 50 MCG/ML SOLUTION FOR INJECTION OR CONCENTRATE FOR SOLUTION FOR INFUSION, PL 23860/0030, Authorised Regulator MHRA |
| Octreotide | SANDOSTATIN AMPOULES 500 MCG/ML SOLUTION FOR INJECTION OR CONCENTRATE FOR SOLUTION FOR INFUSION, PL 23860/0032, Authorised Regulator MHRA |
| Octreotide | SANDOSTATIN LAR 10 MG POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION, PL 23860/0033, Authorised Regulator MHRA |
| Octreotide | SANDOSTATIN LAR 20 MG POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION, PL 23860/0034, Authorised Regulator MHRA |
| Octreotide | SANDOSTATIN LAR 30 MG POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION, PL 23860/0035, Authorised Regulator MHRA |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.